GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,185 Cr | ₹5,484 Cr | ₹4,903 Cr | ₹4,512 Cr | ₹3,713 Cr |
What is the latest Total Liabilities ratio of GRANULES INDIA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹6,185 Cr |
| Mar2024 | ₹5,484 Cr |
| Mar2023 | ₹4,903 Cr |
| Mar2022 | ₹4,512 Cr |
| Mar2021 | ₹3,713 Cr |
How is Total Liabilities of GRANULES INDIA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,185 Cr | 12.78 | |
| Mar2024 | ₹5,484 Cr | 11.84 | |
| Mar2023 | ₹4,903 Cr | 8.68 | |
| Mar2022 | ₹4,512 Cr | 21.52 | |
| Mar2021 | ₹3,713 Cr | - | |
Compare Total Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹22,240.1 Cr | 4% | 17.6% | 80.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | 4% |
17.6% |
80.5% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses